Clinical Trials Directory

Trials / Completed

CompletedNCT03137901

Agreement and Precision of Capstesia, a New Smarphone Application for PPV and CO Monitoring

Agreement and Precision of Capstesia, a New Smarphone Application for PPV and CO Monitoring.

Status
Completed
Phase
Study type
Observational
Enrollment
40 (actual)
Sponsor
Erasme University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study test the agreement and precision of Pulse Pressure Variation (PPV) and Cardiac Output (CO) obtained by the Android application Capstesia™ against another pulse contour CO monitoring ( EV-1000, Edwards Lefesciences, USA)

Detailed description

Pulse pressure variation (PPV) remains a good predictor of fluid responsiveness in the OR. However, PPV can be time-consuming to calculate (manual determination), is not always displayed on monitoring screens nor reliable through visual assessment and needs additional devices to be displayed. A new Android application (Captesia) automatically calculates the PPV utilizing a digital photograph of the arterial waveform from the monitor. The application determines the PPV by selecting peaks and troughs of the arterial curve.

Conditions

Interventions

TypeNameDescription
DEVICECapstesiaPicture of the arterial waveform taken with a smartphone

Timeline

Start date
2017-05-10
Primary completion
2017-06-30
Completion
2017-06-30
First posted
2017-05-03
Last updated
2019-11-26

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT03137901. Inclusion in this directory is not an endorsement.